{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:52:39Z","timestamp":1776495159251,"version":"3.51.2"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"P01-AG02219"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neurobiolaging.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:30:09Z","timestamp":1308875409000},"page":"628.e1-628.e14","source":"Crossref","is-referenced-by-count":37,"title":["Association of ApoE and LRP mRNA levels with dementia and AD neuropathology"],"prefix":"10.1016","volume":"33","author":[{"given":"Afia","family":"Akram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Schmeidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Katsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Hof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahram","family":"Haroutunian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.01.006","article-title":"Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus","volume":"1318","author":"Akram","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0169-328X(02)00203-6","article-title":"LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes","volume":"104","author":"Ar\u00e9lin","year":"2002","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1993.tb03532.x","article-title":"Pre- and postmortem influences on brain RNA","volume":"61","author":"Barton","year":"1993","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-008-0143-3","article-title":"Expression of four housekeeping proteins in elderly patients with schizophrenia","volume":"116","author":"Bauer","year":"2009","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","article-title":"Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent","volume":"843","author":"Beffert","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.R300017-JLR200","article-title":"Functions of lipoprotein receptors in neurons","volume":"45","author":"Beffert","year":"2004","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","article-title":"Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions","volume":"64","author":"Bennett","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","article-title":"Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype","volume":"55","author":"Berg","year":"1998","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0074-7742(09)00409-7","article-title":"Alzheimer's disease genetics current status and future perspectives","volume":"84","author":"Bertram","year":"2009","journal-title":"Int. Rev. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","article-title":"Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease","volume":"33","author":"Bertrand","year":"1995","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","article-title":"ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative","volume":"148","author":"Blacker","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib17","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/hmg\/ddh299","article-title":"Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes","volume":"13","author":"Bray","year":"2004","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib19","doi-asserted-by":"crossref","first-page":"18521","DOI":"10.1016\/S0021-9258(17)32340-2","article-title":"Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons","volume":"269","author":"Bu","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneur.1988.00520250037015","article-title":"Reliability of the Washington University Clinical Dementia Rating","volume":"45","author":"Burke","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2007.09.034","article-title":"Schizophrenia and Sex Associated Differences in the Expression of Neuronal and Oligodendrocyte Specific Genes in Individual Thalamic Nuclei","volume":"98","author":"Byne","year":"2008","journal-title":"Schizo. Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib21a","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jnen\/62.10.999","article-title":"Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and cognitive decline or dementia","volume":"62","author":"Causevic","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.neuroimage.2005.05.015","article-title":"Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study","volume":"27","author":"Ch\u00e9telat","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/8438","article-title":"Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation","volume":"5","author":"Chui","year":"1999","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib26","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's Disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib28","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"8","author":"Deane","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1212\/01.wnl.0000320055.57329.34","article-title":"MRI measures of temporoparietal regions show differential rates of atrophy during prodromal","volume":"71","author":"Desikan","year":"2008","journal-title":"Adv. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib30a","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib31","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.46.6.1746","article-title":"The Clinical Dementia Rating scale: community-based validation of \u201cprofound\u201d and \u201cterminal\u201d stages","volume":"46","author":"Dooneief","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1176\/appi.ajp.158.9.1400","article-title":"N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia","volume":"9","author":"Dracheva","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib33","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib34","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archneur.1995.00540360028012","article-title":"Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients","volume":"52","author":"Giannakopoulos","year":"1995","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.410390110","article-title":"Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease","volume":"39","author":"Gomez-Isla","year":"1996","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","article-title":"Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain","volume":"21","author":"Grehan","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2005.11.001","article-title":"Tau protein abnormalities associated with the progression of alzheimer disease type dementia","volume":"28","author":"Haroutunian","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neurobiolaging.2007.07.021","article-title":"Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia","volume":"30","author":"Haroutunian","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease","volume":"55","author":"Haroutunian","year":"1998","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archneur.56.6.713","article-title":"Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease","volume":"56","author":"Haroutunian","year":"1999","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib42","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1046\/j.1471-4159.1996.66062429.x","article-title":"Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease","volume":"66","author":"Harr","year":"1996","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/neur.1996.0055","article-title":"Amyloid precursor protein mRNAs in Alzheimer's disease","volume":"5","author":"Harrison","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib44","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1002\/j.1460-2075.1988.tb03306.x","article-title":"Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor","volume":"7","author":"Herz","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000017189","article-title":"A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease","volume":"10","author":"Hesse","year":"1999","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib47","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib49","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2000.tb06919.x","article-title":"Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background","volume":"920","author":"Irizarry","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(96)01363-7","article-title":"Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease","volume":"748","author":"Ishii","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jnr.490160123","article-title":"Extensive postmortem stability of RNA from rat and human brain","volume":"16","author":"Johnson","year":"1986","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1523\/JNEUROSCI.18-01-00195.1998","article-title":"Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures","volume":"18","author":"Jord\u00e1n","year":"1998","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib54","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","article-title":"Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease","volume":"49","author":"Kang","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib56","doi-asserted-by":"crossref","first-page":"e7642","DOI":"10.1371\/journal.pone.0007642","article-title":"Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals","volume":"4","author":"Katsel","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib57","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.21-21-08354.2001","article-title":"Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65","volume":"21","author":"Kinoshita","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0006-8993(96)00711-1","article-title":"Cell surface","volume":"740","author":"Knauer","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib59","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","article-title":"Evidence that production and release of amyloid beta-protein involves the endocytic pathway","volume":"269","author":"Koo","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib60","first-page":"991","article-title":"Trafficking of cell-surface amyloid beta-protein precursor","volume":"109","author":"Koo","year":"1996","journal-title":"I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J. Cell Sci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0092-8674(95)90320-8","article-title":"LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation","volume":"82","author":"Kounnas","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.bi.63.070194.003125","article-title":"Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP)","volume":"63","author":"Krieger","year":"1994","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib63","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib64","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid","volume":"270","author":"LaDu","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib66","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/hmg\/6.12.2151","article-title":"Distortion of allelic expression of apolipoprotein E in Alzheimer's disease","volume":"6","author":"Lambert","year":"1997","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib67","first-page":"273","article-title":"Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform","volume":"7","author":"Land\u00e9n","year":"1996","journal-title":"Dementia"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(96)12774-9","article-title":"Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease","volume":"212","author":"Lefranc","year":"1996","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(97)13381-X","article-title":"Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population","volume":"222","author":"Lendon","year":"1997","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1385\/MN:23:1:53","article-title":"Low-density lipoprotein receptor family: endocytosis and signal transduction","volume":"23","author":"Li","year":"2001","journal-title":"Mol. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.biopsych.2006.06.019","article-title":"Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia","volume":"60","author":"Lipska","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib71a","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2007.05.050","article-title":"Expression of APP pathway mRNAs and proteins in Alzheimer's disease","volume":"1161","author":"Matsui","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib72","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.0b013e3181b16431","article-title":"Regional rates of neocortical atrophy from normal aging to early Alzheimer disease","volume":"73","author":"McDonald","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib75","article-title":"Guide to the CERAD Protocol for the Neuropathological Assessment of Alzheimer's Disease","author":"Mirra","year":"1987","journal-title":"CERAD. Durham, NC"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.10086","article-title":"Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease","volume":"51","author":"Mitchell","year":"2002","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(99)04937-5","article-title":"Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease","volume":"355","author":"Mochizuki","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00353892","article-title":"Distribution of the alpha 2-macroglobulin receptor\/low density lipoprotein receptor-related protein in human tissues","volume":"269","author":"Moestrup","year":"1992","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib79","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1074\/jbc.273.9.5013","article-title":"Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain","volume":"273","author":"Moir","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib80","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib82","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib84","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/0264-6021:3470613","article-title":"Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600\/megalin","volume":"347","author":"Oleinikov","year":"2000","journal-title":"Biochem. J"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib85","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1074\/jbc.274.27.18851","article-title":"Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42","volume":"274","author":"Perez","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib86","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","article-title":"The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing","volume":"21","author":"Pietrzik","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib87","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1523\/JNEUROSCI.5451-03.2004","article-title":"FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein","volume":"24","author":"Pietrzik","year":"2004","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib88","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0404.1996.tb00008.x","article-title":"The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia","volume":"93","author":"Pirttila","year":"1996","journal-title":"Acta Neurol. Scand"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib89","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(96)00183-7","article-title":"Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls","volume":"722","author":"Pirttila","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbrainres.2003.08.022","article-title":"Amyloid precursor protein mRNA levels in Alzheimer's disease brain","volume":"122","author":"Preece","year":"2004","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","article-title":"Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases","volume":"55","author":"Purohit","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib93","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jnen\/60.5.430","article-title":"Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro","volume":"60","author":"Qiu","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410370212","article-title":"Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor\/low-density-lipoprotein receptor-related protein","volume":"37","author":"Rebeck","year":"1995","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib95","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1074\/jbc.275.12.8564","article-title":"Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo","volume":"275","author":"Rensen","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib96","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/nm1102-1243","article-title":"The liver X receptor gene team: potential new players in atherosclerosis","volume":"8","author":"Repa","year":"2002","journal-title":"Nat. Med"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib97","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer's disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Review Med"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib97a","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"12","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00001756-200301200-00023","article-title":"Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice","volume":"14","author":"Shie","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib99","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s11064-008-9588-x","article-title":"Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals","volume":"33","author":"Sihlbom","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib100","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: High-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib101","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib101a","first-page":"605","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"5","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/0264-6021:3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem. J"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib103","doi-asserted-by":"crossref","first-page":"33556","DOI":"10.1074\/jbc.273.50.33556","article-title":"Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein","volume":"273","author":"Trommsdorff","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib104","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1074\/jbc.275.10.7410","article-title":"Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP)","volume":"275","author":"Ulery","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib105","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib106","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(00)00051-9","article-title":"Abeta-generating enzymes: recent advances in beta- and gamma-secretase research","volume":"27","author":"Vassar","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.mp.4001830","article-title":"Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders","volume":"11","author":"Vawter","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib108","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","article-title":"Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis","volume":"40","author":"Winkler","year":"1999","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-7091-7508-8_4","article-title":"The prognosis of mild cognitive impairment in the elderly","volume":"54","author":"Wolf","year":"1998","journal-title":"J. Neural Transm. Suppl"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1997.6709","article-title":"Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning","volume":"149","author":"Zarow","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib111","doi-asserted-by":"crossref","first-page":"36180","DOI":"10.1074\/jbc.M604436200","article-title":"Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice","volume":"281","author":"Zerbinatti","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2011.04.010_bib112","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1073\/pnas.0305803101","article-title":"Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein","volume":"101","author":"Zerbinatti","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458011001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:15:44Z","timestamp":1637914544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458011001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0197458011001515"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.04.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}